Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Significant Rise in Meningococcal Disease Cases

19 November 2019


Significant Rise in Meningococcal Disease Cases Among Infants Prompts Health Warning

Parents of infants, early childhood educators and doctors need to be more vigilant in identifying the early stages of meningococcal disease according to health experts.

The call comes as a new Institute of Environmental Science and Research (ESR) report shows there have already been 126 cases of invasive meningococcal disease confirmed so far this year, an approximate 33% increase for the same period last year.

Data also shows that infants aged under one now make up more than a fifth (21%) of all cases of the disease - up from 14% compared to the same time last year.1,

Meningococcal disease is a rare but life-threatening bacterial infection causing two serious illnesses: meningitis (an infection of the membranes that cover the brain) and septicaemia (blood poisoning).

There are five main serogroups, or meningococcal strains: A, B, C, W and Y. 3

Paediatrician Dr Maneesh Deva says it is essential to diagnose meningococcal disease in the early stages as the disease progresses rapidly with severe consequences for patients.

He says while there has been some awareness of the symptomatic or “worrying rash” there are many variations of the illness which makes it hard to diagnose.

“There are many variations to the ‘text-book’ rash. Unfortunately the absence of a rash does not rule out meningococcal disease either.”

In addition Dr Deva says it can be more difficult to diagnose the disease in younger children.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

“Infants can’t tell us how they feel, if they have a headache and other vital information which would help us identify the presence of meningococcal disease. We do have a lower threshold for intervening for these children and we are more likely to keep them in for observation and re-check and reassess.

“We all need to be vigilant not only doctors or parents, but primary care nurses, teachers, friends and family, it's just such a quickly progressing illness, but if we start treatment with antibiotics in a timely fashion the outcome is usually very good,” he says.

Dr Deva says those children born into more socially disadvantaged circumstances are at greater risk of complications.

“While children may have free access to healthcare there are other costs for parents such as childcare for siblings, time off work and transport limitations which can affect how quickly the patient can be seen by a clinician. Like most infections, we do see poorer outcomes for more socially disadvantaged children.”

Dr Deva says resources like Healthline can play an important role in helping parents and are a phone call away, he also suggests accessing the Ministry of Health and Meningitis Foundation website for any additional information.

“I think all parents should feel empowered to access health care in a way which works for them and with the resources they have. We now have safe, proven effective vaccines for meningococcal disease. Although they are currently not funded by the Government that shouldn’t stop parents from strongly considering them,” he says.

Although rare, he says meningococcal disease has the potential to cause permanent damage to the brain or nerves, loss of limbs and in some cases, death. In the early stages of the disease it can be very difficult to tell meningococcal apart from milder diseases.

Symptoms of meningococcal disease can develop rapidly. The first symptoms are usually fever, vomiting, headache and feeling unwell. This can progress rapidly to a non-blanching rash (which doesn’t fade when a glass is rolled over it), neck stiffness, dislike of bright lights and confusion.

New Zealand has a higher rate of invasive meningococcal disease compared with other developed countries such as Australia, the United Kingdom and the United States, and the rate of disease has been increasing since 2014.

From 18 November, New Zealand will be one of the first countries to be part of a new GSK global awareness campaign which features real-life survivors of meningococcal disease and their families, from around the world.

The survivors featured in the campaign each live with long-term effects from the disease, ranging from scarring to prosthetics for limb loss.

A global study of 3,600 parents and caregivers found that half were unsure if their children were missing protection from meningococcal disease.

The research also found only 40% of parents are aware that there are multiple different strains of meningococcal disease and only a third of parents are aware that children who received one meningococcal vaccine may be missing protection from other types of meningococcal disease.13

Meningitis Foundation director Andrea Brady says there is a high level of confusion among New Zealand parents about meningococcal disease, and many still don’t understand how to best protect their children against all of the strains.

“We have many parents say to us they believe their child is protected against meningococcal disease as part of their childhood immunisations. However, the immunisations that are given as part of the routine infant schedule do not protect against meningococcal disease.”

“It is also important that all parents know there are numerous strains of meningococcal disease prevalent in New Zealand.”

“We encourage all parents to talk with their GP or healthcare provider about all of the available vaccines to ensure they have the widest protection possible" she says.

Vaccines are available to help protect against most of the strains, however, no single vaccine protects against all strains. While rare, meningococcal disease can potentially kill within 24 hours, making it vital to be aware of the symptoms and act accordingly. Medical attention should be sought immediately if meningococcal disease is suspected.

Meningococcal vaccines are not currently funded as part of the routine childhood immunisation schedule. For more information about protection options talk to a healthcare professional.

High-res video can be found here
[1] The Institute of Environmental Science and Research. Meningococcal Disease Report October 2019. Available at https://surv.esr.cri.nz/PDF_surveillance/MeningococcalDisease/2019/Oct2019_MeningoReport.pdf Accessed 13 November 2019.
[2] The Institute of Environmental Science and Research. Invasive Meningococcal Disease Quarterly Report January - September 2019. Available at https://surv.esr.cri.nz/PDF_surveillance/MeningococcalDisease/2019/MeningococcalDisease_Q3_2019.pdf. Accessed 14 November 2019.
[3] Ministry of Health website. Meningococcal disease (including meningitis.) Summary Tab. Available at: https://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-illnesses/meningococcal-disease-including-meningitis Accessed 14 November 2019
[4] Rosenstein NE, et al. N Engl J Med 2001; 344(18): 1378–88.
[5] Thompson MJ et al. Lancet. 2006;367:397-403
[6] Ministry of Health website. Meningococcal disease (including meningitis.) Summary Tab. Available at: https://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-illnesses/meningococcal-disease-including-meningitis Accessed 14 November 2019
[7] Thompson MJ et al. Lancet. 2006;367:397-403
[8] The Meningitis Foundation Aotearoa NZ website. Available at https://www.meningitis.org.nz/meningitis_symptoms Accessed 14 November 2019
[9] The Institute of Environmental Science and Research. Meningococcal Disease Report September 2019. Available at https://surv.esr.cri.nz/surveillance/Meningococcal_disease.php Accessed 28 October 2019.
[10] Australian Government Department of Health. Invasive Meningococcal Disease National Surveillance Report Quarter 4 2018. Available here. Accessed 7 November 2018.
[11] CDC. Enhanced Meningococcal Disease Surveillance Report, 2017. Available here. Accessed 1 April 2019.
[12] England ref: Public Health England. Invasive Meningococcal Disease in England: annual laboratory confirmed reports for epidemiological year 2017 to 2018. Available here. Accessed 1 April 2019.
[13] Data on File: 2019N40520901 Parent Awareness Tracker.
[14] Immunisation Advisory Centre. Meningococcal Disease Fact Sheet. Available at https://www.immune.org.nz/sites/default/files/resources/Written%20Resources/DiseaseMeningococcalImac20190530V01Final.pdf. Accessed 14 November 2019
[15] Thompson MJ et al. Lancet.2006;367:397-403
[16] Ministry of Health. Immunisation Handbook 2017 (2nd Edition, March 2018). Available at https://www.health.govt.nz/publication/immunisation-handbook-2017. Accessed 14 November 2019

ends

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.